{"count": 139, "results": [{"_id": "33231125", "pmid": 33231125, "pmcid": "PMC7919225", "title": "Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry", "journal": "Diab Vasc Dis Res", "authors": ["Ritsinger V", "Lagerqvist B", "Lundman P", "Hagström E", "Norhammar A"], "date": "2020-11-01T00:00:00Z", "doi": "10.1177/1479164120973676", "meta_date_publication": "2020 Nov-Dec", "meta_volume": "17", "meta_issue": "6", "meta_pages": "1479164120973676", "score": 50271.25, "text_hl": "To explore real-life use of @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ lowering drugs and prognosis after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@ (@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@AMI@@@) with a special focus on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Ritsinger V, Lagerqvist B, Lundman P, Hagström E, Norhammar A. Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120973676. PMID: 33231125", "BibTeX": "@article{33231125, title={Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry}, author={Ritsinger V and Lagerqvist B and Lundman P and Hagström E and Norhammar A}, journal={Diab Vasc Dis Res}, volume={17}, number={6}, pages={1479164120973676}}"}}, {"_id": "32702900", "pmid": 32702900, "pmcid": "PMC7373575", "title": "Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus", "journal": "Medicine (Baltimore)", "authors": ["Cho EH", "Han K", "Kim B", "Lee DH"], "date": "2020-07-17T00:00:00Z", "doi": "10.1097/MD.0000000000021236", "meta_date_publication": "2020 Jul 17", "meta_volume": "99", "meta_issue": "29", "meta_pages": "e21236", "score": 50265.14, "text_hl": "...For @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@AMI@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy also demonstrated a lower incidence (AHR = 0.852, 95% CI 0.76-0.95) than @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@ did as the reference. ", "citations": {"NLM": "Cho EH, Han K, Kim B, Lee DH. Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus Medicine (Baltimore). 2020 Jul 17;99(29):e21236. PMID: 32702900", "BibTeX": "@article{32702900, title={Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus}, author={Cho EH and Han K and Kim B and Lee DH}, journal={Medicine (Baltimore)}, volume={99}, number={29}, pages={e21236}}"}}, {"_id": "38196460", "pmid": 38196460, "pmcid": "PMC10772430", "title": "Metformin versus sodium glucose co-transporters inhibitors as first-line for atherosclerotic cardiovascular disease: A meta-analysis", "journal": "Pak J Med Sci", "authors": ["Alatawi AM"], "date": "2024-01-01T00:00:00Z", "doi": "10.12669/pjms.40.1.6982", "meta_date_publication": "2024 Jan-Feb", "meta_volume": "40", "meta_issue": "1Part-I", "meta_pages": "209-213", "score": 50261.668, "text_hl": "Sodium-glucose co-transporter inhibitors-2 as first-line therapy showed a lower @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ and @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Alatawi AM. Metformin versus sodium glucose co-transporters inhibitors as first-line for atherosclerotic cardiovascular disease: A meta-analysis Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):209-213. PMID: 38196460", "BibTeX": "@article{38196460, title={Metformin versus sodium glucose co-transporters inhibitors as first-line for atherosclerotic cardiovascular disease: A meta-analysis}, author={Alatawi AM}, journal={Pak J Med Sci}, volume={40}, number={1Part-I}, pages={209-213}}"}}, {"_id": "33234131", "pmid": 33234131, "pmcid": "PMC7687769", "title": "Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient", "journal": "Cardiovasc Diabetol", "authors": ["Nantsupawat T", "Wongcharoen W", "Chattipakorn SC", "Chattipakorn N"], "date": "2020-11-24T00:00:00Z", "doi": "10.1186/s12933-020-01176-4", "meta_date_publication": "2020 Nov 24", "meta_volume": "19", "meta_issue": "1", "meta_pages": "198", "score": 50258.0, "text_hl": "It has been shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was associated with decreased incidence of @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with and without @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@. ", "citations": {"NLM": "Nantsupawat T, Wongcharoen W, Chattipakorn SC, Chattipakorn N. Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient Cardiovasc Diabetol. 2020 Nov 24;19(1):198. PMID: 33234131", "BibTeX": "@article{33234131, title={Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient}, author={Nantsupawat T and Wongcharoen W and Chattipakorn SC and Chattipakorn N}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={198}}"}}, {"_id": "35950214", "pmid": 35950214, "pmcid": "PMC9352811", "title": "Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice", "journal": "Mol Ther Nucleic Acids", "authors": ["Wang M", "Zou J", "Wang J", "Liu M", "Liu K", "Wang N", "Wang K"], "date": "2022-07-11T00:00:00Z", "doi": "10.1016/j.omtn.2022.07.009", "meta_date_publication": "2022 Sep 13", "meta_volume": "29", "meta_issue": "", "meta_pages": "312-328", "score": 50255.934, "text_hl": "Aberrant @GENE_HSF1 @GENE_3297 @@@HSF1@@@ signaling activation underlies @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ amelioration of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ in mice", "citations": {"NLM": "Wang M, Zou J, Wang J, Liu M, Liu K, Wang N, Wang K. Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice Mol Ther Nucleic Acids. 2022 Sep 13;29():312-328. PMID: 35950214", "BibTeX": "@article{35950214, title={Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice}, author={Wang M and Zou J and Wang J and Liu M and Liu K and Wang N and Wang K}, journal={Mol Ther Nucleic Acids}, volume={29}, pages={312-328}}"}}, {"_id": "34625572", "pmid": 34625572, "pmcid": "PMC8501080", "title": "Metformin accelerates zebrafish heart regeneration by inducing autophagy", "journal": "NPJ Regen Med", "authors": ["Xie F", "Xu S", "Lu Y", "Wong KF", "Sun L", "Hasan KMM", "Ma ACH", "Tse G", "Manno SHC", "Tian L", "Yue J", "Cheng SH"], "date": "2021-10-08T00:00:00Z", "doi": "10.1038/s41536-021-00172-w", "meta_date_publication": "2021 Oct 8", "meta_volume": "6", "meta_issue": "1", "meta_pages": "62", "score": 50255.758, "text_hl": "Our results in fish, therefore, suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might also have clinical value for the prevention and amelioration of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@MI@@@ in @SPECIES_9606 @@@humans@@@ by enhancing autophagic activity in the heart.", "citations": {"NLM": "Xie F, Xu S, Lu Y, Wong KF, Sun L, Hasan KMM, Ma ACH, Tse G, Manno SHC, Tian L, Yue J, Cheng SH. Metformin accelerates zebrafish heart regeneration by inducing autophagy NPJ Regen Med. 2021 Oct 8;6(1):62. PMID: 34625572", "BibTeX": "@article{34625572, title={Metformin accelerates zebrafish heart regeneration by inducing autophagy}, author={Xie F and Xu S and Lu Y and Wong KF and Sun L and Hasan KMM and Ma ACH and Tse G and Manno SHC and Tian L and Yue J and Cheng SH}, journal={NPJ Regen Med}, volume={6}, number={1}, pages={62}}"}}, {"_id": "40466424", "pmid": 40466424, "title": "[The role of metformin in the cardiokidney-metabolic patient].", "journal": "Semergen", "authors": ["Arranz Martínez E", "Hernández-Teixidó C", "Ruíz García A"], "date": "2025-06-03T00:00:00Z", "doi": "10.1016/j.semerg.2025.102530", "meta_date_publication": "2025 Jun 3", "meta_volume": "51", "meta_issue": "7", "meta_pages": "102530", "score": 50255.293, "text_hl": "Its main mechanism of action is the reduction of hepatic gluconeogenesis, improving @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity and modulating @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ metabolism. The benefits of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are not limited to glycemic control, as it also has cardiovascular effects, reducing the risk of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@ and cardiovascular mortality in people with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@T2DM@@@. ", "citations": {"NLM": "Arranz Martínez E, Hernández-Teixidó C, Ruíz García A. [The role of metformin in the cardiokidney-metabolic patient]. Semergen. 2025 Jun 3;51(7):102530. PMID: 40466424", "BibTeX": "@article{40466424, title={[The role of metformin in the cardiokidney-metabolic patient].}, author={Arranz Martínez E and Hernández-Teixidó C and Ruíz García A}, journal={Semergen}, volume={51}, number={7}, pages={102530}}"}}, {"_id": "32501595", "pmid": 32501595, "title": "Metformin monotherapy for adults with type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Gnesin F", "Thuesen ACB", "Kähler LKA", "Madsbad S", "Hemmingsen B"], "date": "2020-06-05T00:00:00Z", "doi": "10.1002/14651858.CD012906.pub2", "meta_date_publication": "2020 Jun 5", "meta_volume": "6", "meta_issue": "6", "meta_pages": "CD012906", "score": 50255.03, "text_hl": "Three trial reported on @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@NFMI@@@: in two trials no @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@NFMI@@@ occurred and in one trial 21/1454 @SPECIES_9606 @@@participants@@@ (1.4%) in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group experienced a @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@NFMI@@@ compared with 25/1456 @SPECIES_9606 @@@participants@@@ (1.7%) in the @CHEMICAL_2_4_thiazolidinedione @CHEMICAL_MESH:C089946 @@@thiazolidinedione@@@ group. ", "citations": {"NLM": "Gnesin F, Thuesen ACB, Kähler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020 Jun 5;6(6):CD012906. PMID: 32501595", "BibTeX": "@article{32501595, title={Metformin monotherapy for adults with type 2 diabetes mellitus.}, author={Gnesin F and Thuesen ACB and Kähler LKA and Madsbad S and Hemmingsen B}, journal={Cochrane Database Syst Rev}, volume={6}, number={6}, pages={CD012906}}"}}, {"_id": "37031594", "pmid": 37031594, "pmcid": "PMC10190118", "title": "Administration of Metformin Rescues Age-related Vulnerability to Ischemic Insults through Mitochondrial Energy Metabolism", "journal": "Biochem Biophys Res Commun", "authors": ["Li Z", "Wang H", "Zoungrana LI", "James A", "Slotabec L", "Didik S", "Fatmi MK", "Krause-Hauch M", "Lesnefsky EJ", "Li J"], "date": "2023-06-04T00:00:00Z", "doi": "10.1016/j.bbrc.2023.04.004", "meta_date_publication": "2023 Jun 4", "meta_volume": "659", "meta_issue": "", "meta_pages": "46-53", "score": 50254.945, "text_hl": "...High dose of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ rescues @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarct@@@ in aging.", "citations": {"NLM": "Li Z, Wang H, Zoungrana LI, James A, Slotabec L, Didik S, Fatmi MK, Krause-Hauch M, Lesnefsky EJ, Li J. Administration of Metformin Rescues Age-related Vulnerability to Ischemic Insults through Mitochondrial Energy Metabolism Biochem Biophys Res Commun. 2023 Jun 4;659():46-53. PMID: 37031594", "BibTeX": "@article{37031594, title={Administration of Metformin Rescues Age-related Vulnerability to Ischemic Insults through Mitochondrial Energy Metabolism}, author={Li Z and Wang H and Zoungrana LI and James A and Slotabec L and Didik S and Fatmi MK and Krause-Hauch M and Lesnefsky EJ and Li J}, journal={Biochem Biophys Res Commun}, volume={659}, pages={46-53}}"}}, {"_id": "36564851", "pmid": 36564851, "pmcid": "PMC9789554", "title": "Correction: Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction", "journal": "Stem Cell Res Ther", "authors": ["Yue R", "Fu W", "Liao X", "Lan C", "Liao Q", "Li L", "Yang D", "Xia X", "Chen X", "Zeng C", "Wang WE"], "date": "2022-12-23T00:00:00Z", "doi": "10.1186/s13287-022-03224-0", "meta_date_publication": "2022 Dec 23", "meta_volume": "13", "meta_issue": "1", "meta_pages": "530", "score": 50254.387, "text_hl": "@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@MI@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@; &P < 0.05 vs. ", "citations": {"NLM": "Yue R, Fu W, Liao X, Lan C, Liao Q, Li L, Yang D, Xia X, Chen X, Zeng C, Wang WE. Correction: Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction Stem Cell Res Ther. 2022 Dec 23;13(1):530. PMID: 36564851", "BibTeX": "@article{36564851, title={Correction: Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction}, author={Yue R and Fu W and Liao X and Lan C and Liao Q and Li L and Yang D and Xia X and Chen X and Zeng C and Wang WE}, journal={Stem Cell Res Ther}, volume={13}, number={1}, pages={530}}"}}]}